v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Statement of Comprehensive Income [Abstract]    
Net sales $ 99,369 $ 96,978
Cost of sales:    
Cost of product (excluding amortization) 25,293 27,230
Amortization of patented formulations 2,416 2,392
Total cost of sales 27,709 29,622
Gross profit 71,660 67,356
Operating expenses:    
Selling, general, and administrative 65,951 47,987
Amortization of other intangible assets 10,820 10,893
Total operating expenses 76,771 58,880
Operating (loss) income (5,111) 8,476
Interest expense 7,132 13,725
Interest income (2,702) (5,952)
Other expense (income), net 142 (178)
(Loss) Income before provision for income taxes (9,683) 881
Income tax (benefit) provision (4,396) 416
Net (loss) income $ (5,287) $ 465
Net (loss) income per share:    
Basic (in usd per share) $ (0.01) $ 0.00
Diluted (in usd per share) $ (0.01) $ 0.00
Weighted average common shares outstanding:    
Basic (shares) 669,942,446 664,685,462
Diluted (shares) 669,942,446 666,460,714
Other comprehensive income:    
Unrealized gain on derivatives, net of income tax effect $ 139 $ 17
Total other comprehensive income 139 17
Comprehensive (loss) income $ (5,148) $ 482